KR20110099069A - 진균 및/또는 원생생물 감염의 치료방법 - Google Patents

진균 및/또는 원생생물 감염의 치료방법 Download PDF

Info

Publication number
KR20110099069A
KR20110099069A KR1020117019503A KR20117019503A KR20110099069A KR 20110099069 A KR20110099069 A KR 20110099069A KR 1020117019503 A KR1020117019503 A KR 1020117019503A KR 20117019503 A KR20117019503 A KR 20117019503A KR 20110099069 A KR20110099069 A KR 20110099069A
Authority
KR
South Korea
Prior art keywords
polypeptide
seq
arg lys
peptide
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117019503A
Other languages
English (en)
Korean (ko)
Inventor
커티스 돕슨
Original Assignee
에이아이투 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이아이투 리미티드 filed Critical 에이아이투 리미티드
Publication of KR20110099069A publication Critical patent/KR20110099069A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the groups —CO—N< and, both being directly attached by their carbon atoms to the same carbon skeleton, e.g. H2N—NH—CO—C6H4—COOCH3; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020117019503A 2005-06-28 2006-06-26 진균 및/또는 원생생물 감염의 치료방법 Ceased KR20110099069A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513096.8A GB0513096D0 (en) 2005-06-28 2005-06-28 Treatment of microbial infections
GB0513096.8 2005-06-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020087002160A Division KR20080030060A (ko) 2005-06-28 2006-06-26 진균 및/또는 원생생물 감염의 치료방법

Publications (1)

Publication Number Publication Date
KR20110099069A true KR20110099069A (ko) 2011-09-05

Family

ID=34856225

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020117019503A Ceased KR20110099069A (ko) 2005-06-28 2006-06-26 진균 및/또는 원생생물 감염의 치료방법
KR1020087002160A Ceased KR20080030060A (ko) 2005-06-28 2006-06-26 진균 및/또는 원생생물 감염의 치료방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087002160A Ceased KR20080030060A (ko) 2005-06-28 2006-06-26 진균 및/또는 원생생물 감염의 치료방법

Country Status (14)

Country Link
US (3) US20080207508A1 (cg-RX-API-DMAC7.html)
EP (1) EP1896502B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008546831A (cg-RX-API-DMAC7.html)
KR (2) KR20110099069A (cg-RX-API-DMAC7.html)
CN (1) CN101208355A (cg-RX-API-DMAC7.html)
AU (1) AU2006263600B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612103A2 (cg-RX-API-DMAC7.html)
CA (1) CA2610720A1 (cg-RX-API-DMAC7.html)
DK (1) DK1896502T3 (cg-RX-API-DMAC7.html)
ES (1) ES2427171T3 (cg-RX-API-DMAC7.html)
GB (1) GB0513096D0 (cg-RX-API-DMAC7.html)
PL (1) PL1896502T3 (cg-RX-API-DMAC7.html)
RU (1) RU2008102928A (cg-RX-API-DMAC7.html)
WO (1) WO2007000584A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
ITTO20080894A1 (it) * 2008-12-02 2010-06-03 Bioindustry Park Del Canavese S P A Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso
JP5463515B2 (ja) * 2009-02-12 2014-04-09 独立行政法人農業生物資源研究所 抗微生物ペプチドを固定化した素材
EP2892913A4 (en) * 2012-09-07 2017-01-18 Agency For Science, Technology And Research Peptides and their uses
WO2014053879A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
EP3237436B1 (en) * 2014-12-24 2019-05-01 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of molecules
EP3303376A4 (en) * 2015-05-29 2019-01-23 Hexima Limited IN VIVO METHOD
CN105749250A (zh) * 2016-03-14 2016-07-13 吉林大学 林蛙抗菌肽在治疗灰指甲的药物制备中的用途
US20240197823A1 (en) * 2021-02-12 2024-06-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cationic antimicrobial peptides and uses thereof
KR102677968B1 (ko) * 2021-12-20 2024-06-26 세메스 주식회사 버퍼 유닛 및 이를 포함하는 기판 처리 장치
CN116376795B (zh) * 2023-03-29 2023-11-07 中国水产科学研究院珠江水产研究所 一种表达hsp70的重组乳酸菌及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
GB9705831D0 (en) 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
KR100314721B1 (ko) 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
AU2997099A (en) 1998-03-11 1999-09-27 Duke University Methods of suppressing microglial activation
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US20040014955A1 (en) 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
US20050208078A1 (en) * 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
EP1677763A1 (en) * 2003-10-01 2006-07-12 Children's Hospital &amp; Research Center at Oakland Lipophilic drug delivery vehicle and methods of use thereof
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
ITFI20030324A1 (it) 2003-12-22 2005-06-23 Celbo S R L Gruppo guidafilo per distribuire ed avvolgere filati per formare bobine.
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections

Also Published As

Publication number Publication date
ES2427171T3 (es) 2013-10-29
CN101208355A (zh) 2008-06-25
WO2007000584A8 (en) 2013-01-24
EP1896502A1 (en) 2008-03-12
US8916516B2 (en) 2014-12-23
HK1113162A1 (en) 2008-10-24
US20080207508A1 (en) 2008-08-28
AU2006263600B2 (en) 2012-09-20
JP2008546831A (ja) 2008-12-25
US20150190462A1 (en) 2015-07-09
US20120258907A1 (en) 2012-10-11
CA2610720A1 (en) 2007-01-04
AU2006263600A1 (en) 2007-01-04
RU2008102928A (ru) 2009-08-10
EP1896502B1 (en) 2013-07-31
PL1896502T3 (pl) 2013-12-31
GB0513096D0 (en) 2005-08-03
BRPI0612103A2 (pt) 2011-12-20
DK1896502T3 (da) 2013-10-14
KR20080030060A (ko) 2008-04-03
WO2007000584A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
US8916516B2 (en) Treatment of fungal and/or protist infections
CA2372821C (en) Antimicrobial theta defensins and methods of using same
CA2179286C (en) Broad spectrum antimicrobial compounds and methods of use
KR101306643B1 (ko) 항미생물성 헥사펩티드
EP2994154B1 (en) Antimicrobial peptide
WO2003015809A9 (en) Antimicrobial cationic peptides and formulations thereof
AU2002328203A1 (en) Antimicrobial and anti-inflammatory peptides
WO1999058141A1 (en) Indolicidin analogs and methods of using same
US7745390B2 (en) Antimicrobial peptides
WO2015099535A1 (en) Thrombocidin-derived antimicrobial peptides
HK1113162B (en) Treatment of fungal and/or protist infections
US20060241026A1 (en) Novel cyclic peptides and use thereof as anti-microbial agents
HK1114777B (en) Novel antimicrobial peptides
HK1114777A1 (en) Novel antimicrobial peptides
HK1131789B (en) Improved antimicrobial peptides
HK1131789A1 (en) Improved antimicrobial peptides

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20110822

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110920

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20120713

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110920

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I